marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Iovance Biotherapeutics Cash Flow 2011-2024 | IOVA
Annual Cash Flow Iovance Biotherapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-362 M | -293 M | -228 M | -205 M | -159 M | -101 M | -78.7 M | -32.7 M | -18.4 M | 8.63 M | -3.66 M | -2.24 M | -6.19 M |
Depreciation & Amortization |
11.6 M | 9.31 M | 3.11 M | 1.14 M | 1.17 M | 956 K | 952 K | 978 K | 999 K | 88.2 K | 7.09 K | 6.21 K | 2.7 K |
Accounts Payables |
33.1 M | 26.6 M | 27.4 M | 13.5 M | 15.6 M | 2.74 M | 1.23 M | 863 K | 958 K | 1.25 M | 413 K | 1.1 M | 190 K |
Accounts Receivables |
151 K | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
10.4 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Iovance Biotherapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -122 M | - | - | - | -99.8 M | - | -215 M | - | -73.8 M | - | -174 M | - | -62.4 M | - | -142 M | -102 M | -65.3 M | - | -105 M | -62.9 M | -29.1 M | - | -69.7 M | -41.8 M | -17.8 M | - | -57.7 M | -36.3 M | -18.8 M | - | -20.5 M | - | - | - | - | - | 3.46 M | - | - | - | -2.27 M | - | -1.41 M | -982 K | -300 K | - | -2.24 M | -1.96 M | -760 K | - | -3.48 M | -1.83 M | -564 K |
Depreciation & Amortization |
3 M | 3 M | 2.98 M | - | 2.9 M | 2.9 M | 2.76 M | - | 2.5 M | 2.2 M | 1.8 M | - | 1.77 M | 300 K | 372 K | - | 819 K | 512 K | 252 K | - | 875 K | 560 K | 271 K | - | 704 K | 453 K | 228 K | - | 710 K | 464 K | 221 K | - | 688 K | 540 K | 269 K | - | 691 K | 425 K | 185 K | - | 23 K | 17.7 K | 16.6 K | - | 4.9 K | 3.11 K | 1.96 K | - | 4.66 K | 3.1 K | 1.55 K | - | 55.9 K | 36.8 K | 18.1 K |
Accounts Payables |
31.7 M | 20.4 M | 25.7 M | 33.1 M | 19.3 M | 31.2 M | 31.6 M | 26.6 M | 24.3 M | - | 20.5 M | 27.4 M | 12.2 M | 21.9 M | 13.4 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 2.74 M | 2.74 M | 2.74 M | 2.74 M | 1.23 M | 1.23 M | 1.23 M | 1.23 M | 863 K | 863 K | 863 K | 863 K | 958 K | 958 K | 958 K | 958 K | 1.25 M | 1.25 M | 1.25 M | 1.25 M | 413 K | 413 K | 413 K | 413 K | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 190 K | 190 K | 190 K | 190 K |
Accounts Receivables |
55.8 M | 31.6 M | 234 K | 151 K | - | 33 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
38.6 M | 27.9 M | 17.6 M | 10.4 M | 9.2 M | 9.72 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency